NEURIZON THERAPEUTICS LIMITED
Who is NEURIZON THERAPEUTICS LIMITED?
Neurizon Therapeutics Limited (ASX: NUZ), formerly known as PharmAust, is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Address:
385 BOURKE STREET; SUITE 2, LEVEL 11; MELBOURNE, VICTORIA 3000, AU
Employees by Department
- Operations (1)
- The Rest (5)
- Total (6)
Key Decision Makers
Lidija Damjanovic
Head of Marketing and Corporate Affairs
Martin Engel
Scientific Partnership Lead
Dan O Connell
Chief Financial Officer
John Clark
Chief Operating Officer
Employees by Seniority
C-level
5employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of NEURIZON THERAPEUTICS LIMITED?
- Where is NEURIZON THERAPEUTICS LIMITED's headquarter?
- What NEURIZON THERAPEUTICS LIMITED's spending power?
- Does NEURIZON THERAPEUTICS LIMITED have a presence in the domain it operates in?